{
  "id": 17831230,
  "title": "US approves cheap version of HIV prevention shot",
  "url": "https://urgent.news/2026/11/02/us-approves-cheap-version-of-hiv-prevention-shot",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-02T18:00:51.000Z",
  "source": {
    "name": "Punch Nigeria",
    "slug": "punch-nigeria",
    "url": "https://punchng.com/us-approves-cheap-version-of-hiv-prevention-shot/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The US Food and Drug Administration has approved a generic version of lenacapavir, an injectable HIV prevention medicine administered once every six months. This approval, which Punch Nigeria notes occurred on Monday, is expected to bring the drug closer to markets in low-income countries.\n\nSTAT News reports that the FDA gave tentative approval to Dr. Reddy’s Laboratories to manufacture the generic version, with plans to begin shipping the medicine next month. The generic drug is intended to increase access in dozens of low- and middle-income countries. According to STAT News, the annual cost per person will be $40, a price comparable to daily tablets.\n\nThe brand-name version of the drug, marketed by Gilead Sciences as Yetzugo, was approved by the FDA last year. STAT News describes lenacapavir as a tool that offers virtually complete protection against contracting HIV with a single administration every six months.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}